Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
The University of Texas MD Anderson Cancer Center · Klinikum rechts der Isar · +14 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,740
total citations
- FWCI
- 202.21
- Percentile
- 100%
- References
- 29
Citations per year
Authors
19- PSPadmanee SharmaCorresponding
The University of Texas MD Anderson Cancer Center
- MRMargitta Retz
Klinikum rechts der Isar
- AOArlene O. Siefker‐Radtke
The University of Texas MD Anderson Cancer Center
- ADAri David Baron
California Pacific Medical Center
- ANAndrea Necchi
Fondazione IRCCS Istituto Nazionale dei Tumori
Topics & keywords
Topics
Keywords
- Medicine
- Metastatic Urothelial Carcinoma
- Nivolumab
- Regimen
- Internal medicine
- Clinical endpoint
- Oncology
- Chemotherapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.